| Target Price | $252.96 |
| Price | $225.52 |
| Potential |
12.17%
register free of charge
|
| Number of Estimates | 8 |
|
8 Analysts have issued a price target Assurant 2026 .
The average Assurant target price is $252.96.
This is
12.17%
register free of charge
$267.75
18.73%
register free of charge
$234.32
3.90%
register free of charge
|
|
| A rating was issued by 12 analysts: 10 Analysts recommend Assurant to buy, 2 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Assurant stock has an average upside potential 2026 of
12.17%
register free of charge
|
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Billion $ | 11.88 | 12.81 |
| 6.70% | 7.85% | |
| EBITDA Margin | 10.80% | 10.76% |
| 6.58% | 0.38% | |
| Net Margin | 6.40% | 7.10% |
| 10.89% | 10.93% |
8 Analysts have issued a sales forecast Assurant 2025 . The average Assurant sales estimate is
This results in the following potential growth metrics:
6 Analysts have issued an Assurant EBITDA forecast 2025. The average Assurant EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
9 Assurant Analysts have issued a net profit forecast 2025. The average Assurant net profit estimate is
This results in the following potential growth metrics and future Net Margins:
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share $ | 14.46 | 18.00 |
| 21.00% | 24.48% | |
| P/E | 12.53 | |
| EV/Sales | 0.93 |
9 Analysts have issued a Assurant forecast for earnings per share. The average Assurant EPS is
This results in the following potential growth metrics and future valuations:
| Analyst | Rating | Action | Date |
|---|---|---|---|
| UBS |
Locked
➜
Locked
|
Locked | Nov 10 2025 |
| Piper Sandler |
Locked
➜
Locked
|
Locked | Oct 10 2025 |
| UBS |
Locked
➜
Locked
|
Locked | Oct 08 2025 |
| Morgan Stanley |
Locked
➜
Locked
|
Locked | Oct 07 2025 |
| Morgan Stanley |
Locked
➜
Locked
|
Locked | Aug 18 2025 |
| Keefe, Bruyette & Woods |
Locked
➜
Locked
|
Locked | Aug 12 2025 |
| BMO Capital |
Locked
➜
Locked
|
Locked | Aug 12 2025 |
| Analyst Rating | Date |
|---|---|
|
Locked
UBS:
Locked
➜
Locked
|
Nov 10 2025 |
|
Locked
Piper Sandler:
Locked
➜
Locked
|
Oct 10 2025 |
|
Locked
UBS:
Locked
➜
Locked
|
Oct 08 2025 |
|
Locked
Morgan Stanley:
Locked
➜
Locked
|
Oct 07 2025 |
|
Locked
Morgan Stanley:
Locked
➜
Locked
|
Aug 18 2025 |
|
Locked
Keefe, Bruyette & Woods:
Locked
➜
Locked
|
Aug 12 2025 |
|
Locked
BMO Capital:
Locked
➜
Locked
|
Aug 12 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


